194 results on '"Joehlin-Price A"'
Search Results
2. Cell surface CD55 traffics to the nucleus leading to cisplatin resistance and stemness by inducing PRC2 and H3K27 trimethylation on chromatin in ovarian cancer
3. Adenoid cystic carcinoma of the Bartholin's gland is underpinned by MYB- and MYBL1- rearrangements
4. LCK facilitates DNA damage repair by stabilizing RAD51 and BRCA1 in the nucleus of chemoresistant ovarian cancer
5. LCK facilitates DNA damage repair by stabilizing RAD51 and BRCA1 in the nucleus of chemoresistant ovarian cancer
6. HER2 IHC Expression and Gene Amplification in p53-aberrant High-grade Endometrial Endometrioid Carcinoma Suggests That This Population May Benefit From HER2 Testing and Targeted Therapy
7. Evaluation of Lineage/Site-specific Nuclear Immunohistochemical Markers SATB2, Cyclin D1, SALL4, and BCOR in High-grade Endometrial Carcinomas
8. Genomic analyses of high‐grade neuroendocrine gynecological malignancies reveal a unique mutational landscape and therapeutic vulnerabilities
9. High TGF-β signature predicts immunotherapy resistance in gynecologic cancer patients treated with immune checkpoint inhibition
10. MDM2 amplification in malignant Brenner tumors may play a role in progression to malignancy and aid in separation from urothelial and other ovarian carcinomas
11. Oncologic outcomes of endometrial cancer in patients with low-volume metastasis in the sentinel lymph nodes: An international multi-institutional study
12. Computational image features of immune architecture is associated with clinical benefit and survival in gynecological cancers across treatment modalities
13. High TGF-β signature predicts immunotherapy resistance in gynecologic cancer patients treated with immune checkpoint inhibition
14. Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcoma
15. Case Report: Circulating Tumor DNA Fraction Analysis Using Ultra-Low-Pass Whole-Genome Sequencing Correlates Response to Chemoradiation and Recurrence in Stage IV Small-Cell Carcinoma of the Cervix - A Longitudinal Study
16. Prognostic value of isolated tumor cells in sentinel lymph nodes in low risk endometrial cancer: results from an international multi-institutional study
17. Molecularly Classified Uterine FIGO Grade 3 Endometrioid Carcinomas Show Distinctive Clinical Outcomes But Overlapping Morphologic Features
18. HER2 IHC Expression and Gene Amplification in p53-aberrant High-grade Endometrial Endometrioid Carcinoma Suggests That This Population May Benefit From HER2 Testing and Targeted Therapy
19. Predictors of response to immune checkpoint inhibition in a real world gynecologic cancer population
20. Case report: ACTH-secreting pituitary carcinoma metastatic to the liver in a patient with a history of atypical pituitary adenoma and Cushing’s disease
21. Does the Renal Parenchyma Adjacent to the Tumor Contribute to Kidney Function? A Critical Analysis of Glomerular Viability in Partial Nephrectomy Specimens
22. Supplementary Data from Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer
23. Data from Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer
24. Data from Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer
25. Supplementary Data from Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer
26. Additional file 1 of LCK facilitates DNA damage repair by stabilizing RAD51 and BRCA1 in the nucleus of chemoresistant ovarian cancer
27. Genomic analyses of high‐grade neuroendocrine gynecological malignancies reveal a unique mutational landscape and therapeutic vulnerabilities
28. LCK Facilitates DNA Damage Repair by Stabilizing RAD51 and BRCA1 in the Nucleus of Chemoresistant Ovarian Cancer
29. Evaluation of Lineage/Site-specific Nuclear Immunohistochemical Markers SATB2, Cyclin D1, SALL4, and BCOR in High-grade Endometrial Carcinomas
30. 2022-RA-1052-ESGO Low-risk endometrial cancer and no adjuvant treatment: do isolated tumor cells (ITC) have an effect on recurrence? An international multi-institutional comparative study between ITC and node-negative in sentinel lymph node biopsy
31. Comprehensive evaluation of caspase-14 in vulvar neoplasia: An opportunity for treatment with black raspberry extract
32. LCK Facilitates DNA Damage Repair by Stabilizing RAD51 and BRCA1 in the Nucleus of Chemoresistant Ovarian Cancer
33. Pelvic Cholelithiasis. A Report of 4 Cases
34. Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer
35. 2022-RA-998-ESGO Intermediate-risk endometrial cancer: isolated tumor cells (ITC)versusnode-negative in sentinel lymph node mapping. An international multi-institutional comparative study
36. 2022-RA-1052-ESGO Low-risk endometrial cancer and no adjuvant treatment: do isolated tumor cells (ITC) have an effect on recurrence? An international multi-institutional comparative study between ITC and node-negative in sentinel lymph node biopsy
37. Mismatch repair protein expression in 1049 endometrial carcinomas, associations with body mass index, and other clinicopathologic variables
38. Uterine Mesenchymal Tumors: Hereditary Aspects
39. Programmed Death Ligand 1 Expression Among 700 Consecutive Endometrial Cancers: Strong Association With Mismatch Repair Protein Deficiency
40. Evaluation of Lineage/Site-specific Nuclear Immunohistochemical Markers SATB2, Cyclin D1, SALL4, and BCOR in High-grade Endometrial Carcinomas.
41. Fallbericht: Analyse der zirkulierenden Tumor-DNA-Fraktion mittels Ultra-Low-Pass Whole-Genome Sequencing korreliert bei kleinzelligem Stage-IV-Zervixkarzinom mit Ansprechen auf Radiochemotherapie und Rezidivierung – Eine Längsschnittstudie
42. Minimal Clinical Impact of Intraoperative Examination of Sentinel Lymph Nodes in Patients With Ductal Carcinoma In Situ: An Opportunity for Improved Resource Utilization
43. The Microcystic, Elongated, and Fragmented (MELF) Pattern of Invasion: A Single Institution Report of 464 Consecutive FIGO Grade 1 Endometrial Endometrioid Adenocarcinomas
44. Treatment of Ipilimumab Induced Graves’ Disease in a Patient with Metastatic Melanoma
45. Molecularly Classified Uterine FIGO Grade 3 Endometrioid Carcinomas Show Distinctive Clinical Outcomes But Overlapping Morphologic Features
46. Review of 189 Consecutive Female Genital Skin and Mucosal Biopsies Submitted to an Academic Dermatopathology Practice
47. Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer
48. Computational image features of immune architecture is associated with clinical benefit and survival in gynecological cancers across treatment modalities
49. LCK Regulates Homologous Recombination DNA Repair and Targeting Enhances PARPi Utility in HR Proficient Ovarian Cancer
50. Computational image features of immune architecture is associated with clinical benefit and survival in gynecological cancers across treatment modalities
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.